Why the study?
The atherogenic index of plasma (AIP) predicts atherosclerosis and CVD, but its relationship with markers of endothelial dysfunction and early atherosclerosis in patients with MAFLD required examination.
Key points are not available for this paper at this time.
Population
Patients with MAFLD
Comparison
Relationship of AIP with ADMA, adiponectin, and hs-CRP
Answers are grounded in this paper and cite their sources.
The atherogenic index of plasma (AIP) is a marker used to predict atherosclerosis and cardiovascular disease (CVD). In this study, we examined the relationship of AIP with markers of endothelial dysfunction (ED) [asymmetric dimethylarginine (ADMA) and adiponectin] and early atherosclerosis [high-sensitivity C-reactive protein (hs-CRP)] in patients with metabolic associated fatty liver disease (MAFLD).
No takes yet. Share an insight, caveat, or question.
Kırık et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: